Roth MKM lowered the firm’s price target on Aspen Aerogels (ASPN) to $31 from $36 and keeps a Buy rating on the shares after its Q3 results. The firm is positive on the company’s current positioning, including a clear focus on profitable growth as its management positions the portfolio for a strong secular opportunity, the analyst tells investors in a research note. Roth adds that it anticipates some near-term overhang until DOE loan closure, but also looks for outperformance as profitability continues to ramp.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels price target lowered to $30 from $41 at TD Cowen
- Aspen Aerogels price target lowered to $28 from $33 at Canaccord
- Aspen Aerogels Reports Strong Q3 Growth and Outlook
- Aspen Aerogels price target lowered to $30 from $38 at Craig-Hallum
- Closing Bell Movers: AppLoving up 29% after Q3 earnings beat